Literature DB >> 17963374

Activity of sulfonium bisphosphonates on tumor cell lines.

Yonghui Zhang1, Michael P Hudock, Kilannin Krysiak, Rong Cao, Kyle Bergan, Fenglin Yin, Annette Leon, Eric Oldfield.   

Abstract

We investigated three series of sulfonium bisphosphonates for their activity in inhibiting the growth of three human tumor cell lines. The first series consisted of 6 cyclic sulfonium bisphosphonates, the most active species having an (average) IC50 of 89 microM. The second consisted of 10 phenylalkyl and phenylalkoxy bisphosphonates, the most active species having an IC50 of 18 microM. The third series consisted of 17 n-alkyl sulfonium bisphosphonates, the most active species having an IC50 of approximately 240 nM. Three QSAR models showed that the experimental cell growth inhibition results could be well predicted. We also determined the structures of one sulfonium bisphosphonate bound to farnesyl diphosphate synthase, finding that it binds exclusively to the dimethylallyl diphosphate binding site. These results are of interest since they show that sulfonium bisphosphonates can have potent activity against a variety of tumor cell lines, the most active species having IC50 values much lower than conventional nitrogen-containing bisphosphonates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963374     DOI: 10.1021/jm700991k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Ab initio DFT study of bisphosphonate derivatives as a drug for inhibition of cancer: NMR and NQR parameters.

Authors:  Hussein Aghabozorg; Beheshteh Sohrabi; Sara Mashkouri; Hamid Reza Aghabozorg
Journal:  J Mol Model       Date:  2011-06-02       Impact factor: 1.810

2.  Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.

Authors:  Hani El Moll; Wei Zhu; Eric Oldfield; L Marleny Rodriguez-Albelo; Pierre Mialane; Jérôme Marrot; Neus Vila; Israel Martyr Mbomekallé; Eric Rivière; Carole Duboc; Anne Dolbecq
Journal:  Inorg Chem       Date:  2012-06-22       Impact factor: 5.165

3.  Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Authors:  Amandine Boulmier; Xinxin Feng; Olivier Oms; Pierre Mialane; Eric Rivière; Christopher J Shin; Jiaqi Yao; Tadahiko Kubo; Taisuke Furuta; Eric Oldfield; Anne Dolbecq
Journal:  Inorg Chem       Date:  2017-06-20       Impact factor: 5.165

4.  Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.

Authors:  Cammy K-M Chen; Michael P Hudock; Yonghui Zhang; Rey-Ting Guo; Rong Cao; Joo Hwan No; Po-Huang Liang; Tzu-Ping Ko; Tao-Hsin Chang; Shiou-Chi Chang; Yongcheng Song; Jordan Axelson; Anup Kumar; Andrew H-J Wang; Eric Oldfield
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

5.  In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.

Authors:  Gyongseon Yang; Wei Zhu; Kuglae Kim; Soo Young Byun; Gahee Choi; Ke Wang; Jeong Seok Cha; Hyun-Soo Cho; Eric Oldfield; Joo Hwan No
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

6.  Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators.

Authors:  Yonghui Zhang; Rong Cao; Fenglin Yin; Fu-Yang Lin; Hong Wang; Kilannin Krysiak; Joo-Hwan No; Dushyant Mukkamala; Kevin Houlihan; Jikun Li; Craig T Morita; Eric Oldfield
Journal:  Angew Chem Int Ed Engl       Date:  2010-02-01       Impact factor: 15.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.